These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 18202719)
1. DNA-damage response control of E2F7 and E2F8. Zalmas LP; Zhao X; Graham AL; Fisher R; Reilly C; Coutts AS; La Thangue NB EMBO Rep; 2008 Mar; 9(3):252-9. PubMed ID: 18202719 [TBL] [Abstract][Full Text] [Related]
2. Interaction of E2F7 transcription factor with E2F1 and C-terminal-binding protein (CtBP) provides a mechanism for E2F7-dependent transcription repression. Liu B; Shats I; Angus SP; Gatza ML; Nevins JR J Biol Chem; 2013 Aug; 288(34):24581-9. PubMed ID: 23853115 [TBL] [Abstract][Full Text] [Related]
3. Synergistic function of E2F7 and E2F8 is essential for cell survival and embryonic development. Li J; Ran C; Li E; Gordon F; Comstock G; Siddiqui H; Cleghorn W; Chen HZ; Kornacker K; Liu CG; Pandit SK; Khanizadeh M; Weinstein M; Leone G; de Bruin A Dev Cell; 2008 Jan; 14(1):62-75. PubMed ID: 18194653 [TBL] [Abstract][Full Text] [Related]
4. Synergistic functions of E2F7 and E2F8 are critical to suppress stress-induced skin cancer. Thurlings I; Martínez-López LM; Westendorp B; Zijp M; Kuiper R; Tooten P; Kent LN; Leone G; Vos HJ; Burgering B; de Bruin A Oncogene; 2017 Feb; 36(6):829-839. PubMed ID: 27452520 [TBL] [Abstract][Full Text] [Related]
5. Cyclin F-dependent degradation of E2F7 is critical for DNA repair and G2-phase progression. Yuan R; Liu Q; Segeren HA; Yuniati L; Guardavaccaro D; Lebbink RJ; Westendorp B; de Bruin A EMBO J; 2019 Oct; 38(20):e101430. PubMed ID: 31475738 [TBL] [Abstract][Full Text] [Related]
6. Characterization of E2F8, a novel E2F-like cell-cycle regulated repressor of E2F-activated transcription. Christensen J; Cloos P; Toftegaard U; Klinkenberg D; Bracken AP; Trinh E; Heeran M; Di Stefano L; Helin K Nucleic Acids Res; 2005; 33(17):5458-70. PubMed ID: 16179649 [TBL] [Abstract][Full Text] [Related]
7. E2F7, a novel target, is up-regulated by p53 and mediates DNA damage-dependent transcriptional repression. Carvajal LA; Hamard PJ; Tonnessen C; Manfredi JJ Genes Dev; 2012 Jul; 26(14):1533-45. PubMed ID: 22802528 [TBL] [Abstract][Full Text] [Related]
8. E2F8 is essential for polyploidization in mammalian cells. Pandit SK; Westendorp B; Nantasanti S; van Liere E; Tooten PC; Cornelissen PW; Toussaint MJ; Lamers WH; de Bruin A Nat Cell Biol; 2012 Nov; 14(11):1181-91. PubMed ID: 23064264 [TBL] [Abstract][Full Text] [Related]
9. E2F7 Is a Potent Inhibitor of Liver Tumor Growth in Adult Mice. Moreno E; Toussaint MJM; van Essen SC; Bongiovanni L; van Liere EA; Koster MH; Yuan R; van Deursen JM; Westendorp B; de Bruin A Hepatology; 2021 Jan; 73(1):303-317. PubMed ID: 32259305 [TBL] [Abstract][Full Text] [Related]
11. E2F7 and E2F8 keep the E2F family in balance. Moon NS; Dyson N Dev Cell; 2008 Jan; 14(1):1-3. PubMed ID: 18194644 [TBL] [Abstract][Full Text] [Related]
12. Cloning and characterization of mouse E2F8, a novel mammalian E2F family member capable of blocking cellular proliferation. Maiti B; Li J; de Bruin A; Gordon F; Timmers C; Opavsky R; Patil K; Tuttle J; Cleghorn W; Leone G J Biol Chem; 2005 May; 280(18):18211-20. PubMed ID: 15722552 [TBL] [Abstract][Full Text] [Related]
13. E2F7 overexpression leads to tamoxifen resistance in breast cancer cells by competing with E2F1 at miR-15a/16 promoter. Chu J; Zhu Y; Liu Y; Sun L; Lv X; Wu Y; Hu P; Su F; Gong C; Song E; Liu B; Liu Q Oncotarget; 2015 Oct; 6(31):31944-57. PubMed ID: 26397135 [TBL] [Abstract][Full Text] [Related]
14. Chk1 and 14-3-3 proteins inhibit atypical E2Fs to prevent a permanent cell cycle arrest. Yuan R; Vos HR; van Es RM; Chen J; Burgering BM; Westendorp B; de Bruin A EMBO J; 2018 Mar; 37(5):. PubMed ID: 29363506 [TBL] [Abstract][Full Text] [Related]
15. E2F7 represses a network of oscillating cell cycle genes to control S-phase progression. Westendorp B; Mokry M; Groot Koerkamp MJ; Holstege FC; Cuppen E; de Bruin A Nucleic Acids Res; 2012 Apr; 40(8):3511-23. PubMed ID: 22180533 [TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of E2F7, a novel mammalian E2F family member capable of blocking cellular proliferation. de Bruin A; Maiti B; Jakoi L; Timmers C; Buerki R; Leone G J Biol Chem; 2003 Oct; 278(43):42041-9. PubMed ID: 12893818 [TBL] [Abstract][Full Text] [Related]
17. Expression and prognostic role of E2F transcription factors in high-grade glioma. Yu H; Li Z; Wang M CNS Neurosci Ther; 2020 Jul; 26(7):741-753. PubMed ID: 32064771 [TBL] [Abstract][Full Text] [Related]
18. E2F7, a novel E2F featuring DP-independent repression of a subset of E2F-regulated genes. Di Stefano L; Jensen MR; Helin K EMBO J; 2003 Dec; 22(23):6289-98. PubMed ID: 14633988 [TBL] [Abstract][Full Text] [Related]
19. E2F8 as a Novel Therapeutic Target for Lung Cancer. Park SA; Platt J; Lee JW; López-Giráldez F; Herbst RS; Koo JS J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26089541 [TBL] [Abstract][Full Text] [Related]
20. E2F7 can regulate proliferation, differentiation, and apoptotic responses in human keratinocytes: implications for cutaneous squamous cell carcinoma formation. Endo-Munoz L; Dahler A; Teakle N; Rickwood D; Hazar-Rethinam M; Abdul-Jabbar I; Sommerville S; Dickinson I; Kaur P; Paquet-Fifield S; Saunders N Cancer Res; 2009 Mar; 69(5):1800-8. PubMed ID: 19223542 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]